2022
DOI: 10.1097/pts.0000000000001057
|View full text |Cite
|
Sign up to set email alerts
|

Intravenous Smart Pumps at the Point of Care: A Descriptive, Observational Study

Abstract: ObjectiveThis study was conducted to advance understanding of intravenous (IV) smart pump medication administration practices using the Baxter Spectrum IQ. The primary objective was to observe adherence with manufacturer required IV smart pump system setup at the point of care during actual clinical use.MethodsThe study was conducted in a 285-bed acute care community hospital near Boston, Massachusetts. The study design was observational and noninterventional, and all data were collected by a single observer. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 20 publications
0
6
0
Order By: Relevance
“…Finally, innovation in IV smart pumps to develop technical solutions for as many usability issues as possible is needed, including the development of additional choices that do not require a head-height differential for secondary medication infusion. 3,32 With the high level of demand for clinicians at the point of care, manufacturers have the responsibility to improve both clinical workflow and patient safety by creating innovative technology solutions to improve IV smart pump usability in this very important area of patient safety.…”
Section: Conclusion and Implications For Future Researchmentioning
confidence: 99%
See 2 more Smart Citations
“…Finally, innovation in IV smart pumps to develop technical solutions for as many usability issues as possible is needed, including the development of additional choices that do not require a head-height differential for secondary medication infusion. 3,32 With the high level of demand for clinicians at the point of care, manufacturers have the responsibility to improve both clinical workflow and patient safety by creating innovative technology solutions to improve IV smart pump usability in this very important area of patient safety.…”
Section: Conclusion and Implications For Future Researchmentioning
confidence: 99%
“…1 Although there are different types of infusion pumps, large-volume IV smart pumps are the most widely used in US acute care hospitals because they can administer large amounts of both fluids and medications. [2][3][4] Through our experiences as practicing nurses, we know the difficulty first hand in trying to juggle multiple patient care tasks while simultaneously having to safely administer potent IV medications with significant potential side effects. The reality of programming an IV smart pump is that the delivery of even a single dose of medication involves multiple steps and keystrokes, each of which introduces a potential opportunity for error.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“… 15 Typical examples of defence systems include smart pumps, which have been shown to be effective in preventing errors. However, they can also introduce error-inducing factors, such as procedure deviations 16 17 and alert fatigue. 18 Furthermore, previously reported risk countermeasures have used root cause analysis (RCA) tools to identify why accidents occur and how to prevent their recurrence (US Department of Veterans Affairs and Veterans Health Administration National Center for Patient Safety) by incorporating resilience engineering techniques.…”
Section: Introductionmentioning
confidence: 99%
“…Medication errors are the most probable cause of medical injuries. It is a broad term that refers to the numerous and different ways in which IV infusions can go incorrectly at nearly every stage of the medication delivery process [1]. Medication errors 4 2 T can endanger patients and place a financial burden on hospitals and health care providers.…”
Section: Introductionmentioning
confidence: 99%